Tim Hewitson
Tim Hewitson
Department of Nephrology, Royal Melbourne Hospital
Verified email at mh.org.au
Cited by
Cited by
Fibroblast differentiation in wound healing and fibrosis
IA Darby, TD Hewitson
International review of cytology 257, 143-179, 2007
The phenotype and fate of the antibody‐forming cells of the splenic foci
KGC Smith, TD Hewitson, GJV Nossal, DM Tarlinton
European journal of immunology 26 (2), 444-448, 1996
Renal tubulointerstitial fibrosis: common but never simple
TD Hewitson
American Journal of Physiology-Renal Physiology 296 (6), F1239-F1244, 2009
Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice
IA Darby, T Bisucci, TD Hewitson, DG MacLellan
The international journal of biochemistry & cell biology 29 (1), 191-200, 1997
The role of tubulointerstitial injury in chronic renal failure
GJ Becker, TD Hewitson
Current opinion in nephrology and hypertension 9 (2), 133-138, 2000
Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria
JL Taft, CJ Nolan, SP Yeung, TD Hewitson, FI Martin
Diabetes 43 (8), 1046-1051, 1994
Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat
JM Forbes, TD Hewitson, GJ Becker, CL Jones
Kidney international 57 (6), 2375-2385, 2000
Hypoxia and hypoxia signaling in tissue repair and fibrosis
Z Lokmic, J Musyoka, TD Hewitson, IA Darby
International review of cell and molecular biology 296, 139-185, 2012
Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells
V Perkovic, TD Hewitson, KJ Kelynack, M Martic, MG Tait, GJ Becker
Kidney and Blood Pressure Research 26 (1), 27-33, 2003
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
I Mookerjee, TD Hewitson, ML Halls, RJ Summers, ML Mathai, ...
The FASEB journal 23 (4), 1219-1229, 2009
Interstitial myofibroblasts in IgA glomerulonephritis
TD Hewitson, GJ Becker
American journal of nephrology 15 (2), 111-117, 1995
Relaxin-1–deficient mice develop an age-related progression of renal fibrosis
CS Samuel, C Zhao, CP Bond, TD Hewitson, EP Amento, RJ Summers
Kidney international 65 (6), 2054-2064, 2004
Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt‐induced hypertension in mice
SM Krishnan, JK Dowling, YH Ling, H Diep, CT Chan, D Ferens, MM Kett, ...
British journal of pharmacology 173 (4), 752-765, 2016
Animal models of chronic kidney disease: useful but not perfect
GJ Becker, TD Hewitson
Nephrology Dialysis Transplantation 28 (10), 2432-2438, 2013
Drugs of the future: the hormone relaxin
CS Samuel, TD Hewitson, EN Unemori, MLK Tang
Cellular and molecular life sciences 64 (12), 1539-1557, 2007
Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy
CS Samuel, TD Hewitson, Y Zhang, DJ Kelly
Endocrinology 149 (7), 3286-3293, 2008
Pirfenidone reduces in vitro rat renal fibroblast activation and mitogenesis.
TD Hewitson, KJ Kelynack, MG Tait, M Martic, CL Jones, SB Margolin, ...
Journal of nephrology 14 (6), 453-460, 2001
Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro
R Masterson, TD Hewitson, K Kelynack, M Martic, L Parry, R Bathgate, ...
Nephrology Dialysis Transplantation 19 (3), 544-552, 2004
Interstitial myofibroblasts in experimental renal infection and scarring
TD Hewitson, HL Wu, GJ Becker
American journal of nephrology 15 (5), 411-417, 1995
Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
BSM Chow, M Kocan, S Bosnyak, M Sarwar, B Wigg, ES Jones, ...
Kidney international 86 (1), 75-85, 2014
The system can't perform the operation now. Try again later.
Articles 1–20